Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Highbroad Advanced Material
301321
4
WuHan Hvsen Biotechnology
300871
5
TRI-PRIME GENE
837344
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 14.64%-25.96M | -239.70%-8.98M | 293.96%8.99M | -84.37%1.32M | 13.57%-27.29M | -106.29%-30.42M | 86.76%-2.64M | -138.65%-4.63M | 8.44M | -365.71%-31.58M |
Net income from continuing operations | -78.39%-77M | 59.46%-6.09M | -435.07%-27.45M | 65.62%-1.78M | -133.66%-41.69M | -574.57%-43.17M | 19.52%-15.02M | -185.84%-5.13M | ---5.18M | -383.85%-17.84M |
Operating gains losses | 2,403.27%9.86M | -1,871.74%-9.84M | --20.11M | -93.64%-883K | -10.44%472K | 73.43%-428K | -244.22%-499K | --0 | ---456K | 141.37%527K |
Depreciation and amortization | -3.61%7.74M | -3.36%1.93M | -5.05%1.9M | -3.21%1.93M | -2.84%1.98M | 0.17%8.03M | 0.81%2M | -49.44%2M | --1.99M | -1.92%2.04M |
Deferred tax | 106.33%977K | --0 | --0 | --0 | 118.13%977K | -468.33%-15.44M | -272.30%-6.89M | -1,068.91%-1.87M | ---1.29M | ---5.39M |
Other non cash items | -2.79%21.75M | -6.12%5.43M | -181.86%-4.67M | -148.68%-2.67M | 338.09%23.66M | 8.48%22.37M | 7.19%5.78M | -44.84%5.71M | --5.48M | 10.75%5.4M |
Change In working capital | 94.42%-1.09M | -64.92%2.64M | 237.63%13.32M | -90.40%304K | 15.61%-17.35M | 64.28%-19.56M | 145.84%7.51M | 41.03%-9.68M | --3.17M | 6.35%-20.56M |
-Change in receivables | -58.25%124K | -136.92%-3.09M | 379.98%7.3M | -198.76%-4.94M | 108.13%851K | 101.80%297K | 166.45%8.36M | 52.00%-2.61M | --5M | -794.62%-10.46M |
-Change in payables and accrued expense | -364.10%-11.52M | -141.56%-1.43M | 2.44%-1.48M | 30.73%5.28M | -768.06%-13.89M | 114.56%4.36M | 131.90%3.44M | 35.18%-1.52M | --4.04M | 90.49%-1.6M |
-Change in other current liabilities | --10M | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
-Change in other working capital | 101.26%305K | 266.76%7.15M | 54.98%-2.5M | 99.40%-35K | 49.25%-4.31M | -191.85%-24.22M | -161.47%-4.29M | 35.72%-5.55M | ---5.87M | -28.07%-8.5M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 14.64%-25.96M | -239.70%-8.98M | 293.96%8.99M | -84.37%1.32M | 13.57%-27.29M | -106.29%-30.42M | 86.76%-2.64M | -138.65%-4.63M | --8.44M | -365.71%-31.58M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -29.55%-6.79M | -2,018.47%-4.78M | -77.84%-1.38M | 309.74%1.53M | 45.81%-2.16M | 58.88%-5.24M | 108.11%249K | 90.12%-776K | -729K | -119.39%-3.98M |
Capital expenditure reported | 9.91%-5.53M | -65.27%-1.26M | -70.50%-1.31M | 10.23%-886K | 42.62%-2.08M | 28.04%-6.14M | 67.25%-763K | 85.70%-766K | ---987K | -327.21%-3.63M |
Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | -238.34%-1.25M | -447.43%-3.52M | -640.00%-74K | 836.05%2.42M | 78.31%-77K | 123.35%905K | 258.13%1.01M | 99.57%-10K | --258K | 61.66%-355K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -29.55%-6.79M | -2,018.47%-4.78M | -77.84%-1.38M | 309.74%1.53M | 45.81%-2.16M | 58.88%-5.24M | 108.11%249K | 90.12%-776K | ---729K | -119.39%-3.98M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 831.68%45.45M | 34.82%-1.29M | 46.75M | 8.33%-11K | 0 | 79.30%-6.21M | 72.75%-1.98M | 0 | -12K | 38.24%-4.22M |
Net issuance payments of debt | --48.75M | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | 74.02%-4.22M | --0 | --0 | ---1K | -3.91%-4.22M |
Net other financing activities | -65.73%-3.3M | 34.82%-1.29M | ---2M | ---- | ---- | -62.45%-1.99M | ---1.98M | --0 | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 831.68%45.45M | 34.82%-1.29M | --46.75M | 8.33%-11K | --0 | 79.30%-6.21M | 72.75%-1.98M | --0 | ---12K | 38.24%-4.22M |
Net cash flow | ||||||||||
Beginning cash position | -24.43%129.52M | 17.46%157.26M | -26.13%102.9M | -23.96%100.07M | -24.43%129.52M | -25.12%171.38M | -33.61%133.89M | -34.74%139.3M | -38.34%131.6M | -25.12%171.38M |
Current changes in cash | 130.35%12.7M | -244.05%-15.04M | 1,104.97%54.36M | -63.14%2.84M | 25.97%-29.45M | 27.17%-41.87M | 85.56%-4.37M | 54.05%-5.41M | --7.69M | -157.81%-39.78M |
End cash Position | 9.81%142.22M | 9.81%142.22M | 17.46%157.26M | -26.13%102.9M | -23.96%100.07M | -24.43%129.52M | -24.43%129.52M | -33.61%133.89M | -34.74%139.3M | -38.34%131.6M |
Free cash flow | 13.85%-31.5M | -200.62%-10.24M | 242.25%7.68M | -94.20%432K | 16.56%-29.37M | -57.03%-36.56M | 84.72%-3.41M | -181.43%-5.4M | --7.45M | -361.42%-35.2M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |